Rchr
J-GLOBAL ID：201901005200040780
Update date: Feb. 07, 2024
Ohashi Ayaka
オオハシ アヤカ | Ohashi Ayaka
Affiliation and department：
Job title：
Assistant Professor
Research field (1)：
Hematology and oncology
Research theme for competitive and other funds (4)：
- 2020 - 2022 慢性活動性EBウイルス感染症における血管障害発症機構の解明と治療法の開発
- 2019 - 2020 CAEBVにおけるEBウイルス由来RNAの解析:発症への関与と治療標的の可能性
- 2016 - 2018 腫瘍および血管内皮細胞におけるRNase inhibitorの発現と分泌
- 2014 - 2016 血液凝固系に関与するRNase 1、RNase inhibitorの血管内皮細胞と血球における発現と局在
Papers (11)：
-
Miwako Nishio, Minori Saito, Mayumi Yoshimori, Yuki Kumaki, Ayaka Ohashi, Eri Susaki, Ichiro Yonese, Megumi Sawada, Ayako Arai. Clinical significance of anti-Epstein-Barr virus antibodies in systemic chronic active Epstein-Barr virus disease. Frontiers in Microbiology. 2024. 14
-
Yu Uemura, Kumi Oshima, Aika Fuseya, Akane Hosokai, Ayaka Ohashi, Masatoshi Kanno, Ayako Arai. Aortitis after administration of pegfilgrastim to a healthy donor for peripheral blood stem cell collection. International Journal of Hematology. 2023. 118. 6. 772-775
-
Yu Uemura, Ayaka Ohashi, Mayumi Yoshimori, Miwako Nishio, Tsuneaki Hirakawa, Norio Shimizu, Naomi Wada, Ken-Ichi Imadome, Ayako Arai. Plasma interferon-γ concentration: a potential biomarker of disease activity of systemic chronic active Epstein-Barr virus infection. Frontiers in Virology. 2022. 2
-
Ayaka Ohashi, Yu Uemura, Mayumi Yoshimori, Naomi Wada, Ken-Ichi Imadome, Kazuo Yudo, Takatoshi Koyama, Norio Shimizu, Miwako Nishio, Ayako Arai. The Plasma Level of Interleukin-1β Can Be a Biomarker of Angiopathy in Systemic Chronic Active Epstein-Barr Virus Infection. Frontiers in Microbiology. 2022. 13
-
Oshima K, Yoshimori M, Ohashi A, Nishio M, Shimizu N, Arai A. Simvastatin Induces Anti-Tumor Effects on Systemic CAEBV In Vitro and In Vivo. Journal of St. Marianna University. 2022. in press
ｍore...
Patents (1)：
-
慢性活動性Epatein-Barrウイルス感染症(CAEBV)の検出方法
Lectures and oral presentations (23)：
-
BCL2 and BCL-xL inhibitors combat both tumor and inflammation of chronic active EBV infection
(2022)
-
The Effects of BCL2 Inhibitors on Chronic Active EBV Infections, an Intractable T- or NK-cell Lymphoid Neoplasm
(2022)
-
HLA 半合致同種造血幹細胞移植症後の;Human herpesvirus;型脳症
(第35回ヘルペスウイルス研究会 2022)
-
慢性活動性Eウイルス感染症における血清中抗体価の検討
(第35回ヘルペスウイルス研究会 2022)
-
HLA半合致末梢血幹細胞移植を行った慢性活動性EBウイルス感染症
(第44回日本造血・免疫細胞療法学会総会 2022)
ｍore...
Education (4)：
- 2016 - 2019 Tokyo Medical and Dental University
- 2016 - 2018 Justus-Liebig University Department of Biochemistry, Faculty of Medicine
- 2014 - 2016 Tokyo Medical and Dental University
- 2010 - 2014 Tokyo Medical and Dental University Faculty of Medicine
Professional career (1)：
Work history (2)：
- 2020/03 - 現在 St.Marianna University School of Medicine
- 2019/04 - 2020/02 Tokyo Medical and Dental University Graduate School of Medical and Dental Sciences
Awards (2)：
- 2022/11 - St. Marianna University School of Medicine Maeda Prize
- 2014/03 - 中谷・椎名学術奨励賞
Association Membership(s) (3)：
日本癌学会
, 日本臨床衛生検査技師会
, 日本血液学会
